PEDIATRIC INTENSIVE CARE C PROTEIN HEMOSTASIS STUDY - ND
- Conditions
- SEVERE SEPSIS/ SEPTIC SHOCK
- Registration Number
- EUCTR2009-014420-37-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA ISTITUTI CLINICI DI PERFEZIONAMENTO DI MILANO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
SEVERE SEPSIS/ SEPTIC SHOCK;
AGE: 6 MONTHS - 16 YEARS
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
TREATMENT WITH ATIII
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: TO EVALUATE THE ANTINFLAMMATORY AND ANTITHROMBOTIC EFFECT OF PROTEIN C;Secondary Objective: TO EVALUATE MORBILITY AND ORGAN FAILURE;Primary end point(s): TO EVALUATE THE ANTINFLAMMATORY AND ANTITHROMBOTIC EFFECT OF PROTEIN C
- Secondary Outcome Measures
Name Time Method